Friday, November 7, 2025

Bonus Shares Alert: Dr Lal announces first ever free share issue, declares dividend; Check details

Date:

Shares of Dr. Lal Pathlabs Ltd. are currently trading little changed amidst volatile moves on Friday, October 31, after its results announcement for the September quarter.Along with the results, the board also announced a bonus issue of shares. The company will issue one bonus share for every one share held by shareholders as on the record date.

In addition to the bonus, the board also announced that it has approved a dividend payout of ₹7 per share.

This is the first instance that Dr. Lal Pathlabs will be issuing bonus shares to its shareholders.While Dr. Lal had never considered a bonus or a stock split before this one, it has regularly paid dividends to its shareholders. Since July 2016, Dr. Lal has paid dividends worth nearly ₹133 per share to its shareholders, including ₹24 per share since November last year.

Record date for the interim dividend has been fixed as November 7. Record date for the bonus issue is yet to be announced.

As of the September quarter shareholding pattern uploaded on the BSE, Dr. Lal Pathlabs had over 1.05 lakh retail shareholders, or those with an authorised share capital of up to ₹2 lakh, who owned a stake in the company. Promoter shareholding stands at 53.21%.

Shares of Dr. Lal Pathlabs Ltd. are currently trading flat at ₹3,090.6. The stock has remained flat over the course of the year, as well as the last one month.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Kirloskar Brothers Q2 net profit declines 25.8% YoY amid cost pressures

Kirloskar Brothers Ltd reported a 25.8% year-on-year (YoY) decline...

Trump says he will not attend G20 Summit in South Africa

US President Donald Trump has said he will not...

Massive Flight Delays At Delhi Airport, ATC Glitch Disrupts Air Travel Across North India | Mobility News

New Delhi: Flight operations at Delhi’s Indira Gandhi International...

Gland Pharma Q2 net profit up 12% to ₹184 crore on higher revenue, R&D, new US launches

Contract development and manufacturing organisation and an injectables firm,...